Femtech At Work
Femtech At Work
Podcast Description
Femtech At Work is a new podcast that showcases inspiring femtech founders, corporate champions of women’s health in the workplace, and ecosystem innovators. Starting off in Hong Kong we will travel across Asia and Oceania and the rest of the world to explore the most innovative new women’s health solutions around reproductive health and diseases that disproportionately affect women, talk about the challenges and opportunities of starting a women’s health company and the role of the workplace for impact and change.
Podcast Insights
Content Themes
The podcast focuses on women's health, reproductive rights, and femtech innovations, with episodes covering topics like bridging the gap in women's healthcare at the workplace, advancements in endometriosis care, precision health for women, and the importance of employer-sponsored health initiatives.
Femtech At Work is a new podcast that showcases inspiring femtech founders, corporate champions of women’s health in the workplace, and ecosystem innovators.
Starting off in Hong Kong we will travel across Asia and Oceania and the rest of the world to explore the most innovative new women’s health solutions around reproductive health and diseases that disproportionately affect women, talk about the challenges and opportunities of starting a women’s health company and the role of the workplace for impact and change.
What if a simple test could change the course of a pregnancy? Every pregnant woman deserves access to accurate and reliable information about their pregnancy. But what if that information wasn’t available to everyone? Join us as we explore the shocking truth about prenatal testing and meet the entrepreneur on a mission to change it and discover how she’s transforming the future of maternal healthcare.
Today, we have Ella Fung, Co-founder and CEO of Rosalind DX, a cutting-edge biotech company transforming prenatal testing. Ella shares her inspiring journey, from scientist to entrepreneur, and reveals the challenges and triumphs of building a game-changing startup. She also dives into the world of prenatal testing, discussing the current limitations and inequities in access to accurate data. She explains how Rosalind DX’s innovative approach is bridging this gap, providing women with reliable and actionable information to inform their reproductive choices. This conversation also touches on the importance of support systems, self-care, and mentorship for founders, particularly women in STEM.(Science, Technology, Engineering, and Mathematics) Let’s dive in!
Key Takeaways:
- What’s behind the alarming data gap in women’s health, and how AI can help fill it
- Who are the essential players you need to succeed as a founder, and how to find them
- Why prioritizing your well-being is no longer a luxury, but a necessity for entrepreneurs
- How Rosalind DX is pioneering a new era in prenatal testing, and what this breakthrough means for women globally
Resources:
Ella Fung: LinkedIn
Rosalind Dx: LinkedIn
Rosalind Dx: https://www.rosalinddx.com/
Maaike Steinebach : LinkedIn
Website Femtech Future https://www.femtechfuture.com
Instagram Femtech Future: @femtech_future
Thank you for tuning in to this inspiring conversation with Ella Fung. If you’re as passionate about revolutionizing maternal healthcare as we are, please share this episode with your network and help amplify Ella’s remarkable work. Join the movement to empower women and transform maternal healthcare. Follow Rosalind DX on social media and stay updated on their groundbreaking work. Thank you and see you on our next episode!
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.